Product Information
INTUNIV ER 3 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $9.2943 per EA under NDC 54092051702. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on Sep 2, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the guanfacine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092051702
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GUANFACINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022037FDA Approved
9/2/2009
TE Code
AB
On Market Since
9/2/2009
Pharmacological Classes
Price Statistics
The NADAC for INTUNIV ER 3 MG TABLET has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 20.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2943 per EA |
|---|---|
| All-time high | $9.4079 (Mar 16, 2016) |
| All-time low | $7.7301 (Nov 28, 2013) |
| 52-week high | $9.3704 |
| 52-week low | $9.2943 |
| Median price | $9.3224 |
| Average price | $9.1805 |
| Largest weekly change | +12.0% (Jul 9, 2014) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INTUNIV ER 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INTUNIV ER 3 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $9.2943 per EA (NDC 54092051702), effective Aug 19, 2026.
How has the price of INTUNIV ER 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for INTUNIV ER 3 MG TABLET has risen 20.2%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INTUNIV ER 3 MG TABLET?
Since Nov 28, 2013, the NADAC for INTUNIV ER 3 MG TABLET has ranged from a low of $7.7301 (Nov 28, 2013) to a high of $9.4079 (Mar 16, 2016), with a median of $9.3224 per EA.
Are there cheaper alternatives to INTUNIV ER 3 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GUANFACINE HCL ER 3 MG TABLET, is $0.1660 per EA — about 98% below INTUNIV ER 3 MG TABLET.
Who manufactures INTUNIV ER 3 MG TABLET?
INTUNIV ER 3 MG TABLET (NDC 54092051702) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.